Trifluridine
Back to searchMolecule Structure
Scientific Name
Trifluridine
Description of the Drug
Trifluridine is a nucleoside metabolic inhibitor used to treat keratoconjunctivitis and epithelial keratitis caused by simplex virus, and as a part of chemotherapy for certain types of metastatic gastrointestinal cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00432
http://www.drugbank.ca/drugs/DB00432
Brand Name(s)
T.f.t., Trifluridine, Triherpine, Viroptic
Company Owner(s)
Sandoz Inc, Akorn Operating Co Llc, Monarch Pharmaceuticals Llc, Taiho Oncology Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2366042 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3479 | |||||
| PharmGKB | PA451775 | |||||
| Human Metabolome Database | HMDB0014576 | |||||
| DrugBank | DB00432 | |||||
| PubChem: Thomson Pharma | 14849367 | 14751529 | ||||
| PubChem | 6256 | |||||
| LINCS | LSM-5217 | |||||
| Nikkaji | J2.814B | |||||
| BindingDB | 50132298 | |||||
| EPA CompTox Dashboard | DTXSID4046602 | |||||
| DrugCentral | 2743 | |||||
| Brenda | 209608 | 252867 | 42444 | 252862 | 91973 | 210497 |
| Guide to Pharmacology | 8697 | |||||
| rxnorm | VIROPTIC | TRIFLURIDINE | ||||
| PubChem: Drugs of the Future | 12014784 | |||||
| ChEBI | 75179 | |||||
| ZINC | ZINC000003842753 |
